English
简体中文
Total: £ 56.28
Published Date: 2024-12-06 | Pages: 89 | Tables: 156 | Medical Care
The growth is expected to be driven by increased demand for minimally or noninvasive neurosurgeries, rising prevalence of non-traumatic hydrocephalus, and rising adoption of technologically improved devices.
The global market for Acute External Ventricular Drain was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Acute External Ventricular Drain was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acute External Ventricular Drain was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Acute External Ventricular Drain was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Acute External Ventricular Drain include Medtronic, Integra LifeSciences Corporation, Natus Medical Incorporated, Fuji Systems, Spiegelberg GmbH, SOPHYSA and Neuromedex, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acute External Ventricular Drain, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acute External Ventricular Drain by region & country, by Type, and by Application.
The Acute External Ventricular Drain market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute External Ventricular Drain.
Market Segmentation
By Company
Medtronic
Integra LifeSciences Corporation
Natus Medical Incorporated
Fuji Systems
Spiegelberg GmbH
SOPHYSA
Neuromedex
Segment by Type:
Traumatic Brain Injury
Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Other Non-traumatic Hydrocephalus Conditions
Segment by Application
Pediatric
Adult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acute External Ventricular Drain manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acute External Ventricular Drain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acute External Ventricular Drain in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Acute External Ventricular Drain Product Introduction
1.2 Global Acute External Ventricular Drain Market Size Forecast
1.3 Acute External Ventricular Drain Market Trends & Drivers
1.3.1 Acute External Ventricular Drain Industry Trends
1.3.2 Acute External Ventricular Drain Market Drivers & Opportunity
1.3.3 Acute External Ventricular Drain Market Challenges
1.3.4 Acute External Ventricular Drain Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Acute External Ventricular Drain Players Revenue Ranking (2023)
2.2 Global Acute External Ventricular Drain Revenue by Company (2019-2024)
2.3 Key Companies Acute External Ventricular Drain Manufacturing Base Distribution and Headquarters
2.4 Key Companies Acute External Ventricular Drain Product Offered
2.5 Key Companies Time to Begin Mass Production of Acute External Ventricular Drain
2.6 Acute External Ventricular Drain Market Competitive Analysis
2.6.1 Acute External Ventricular Drain Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Acute External Ventricular Drain Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute External Ventricular Drain as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Traumatic Brain Injury
3.1.2 Subarachnoid Hemorrhage
3.1.3 Intracerebral Hemorrhage
3.1.4 Other Non-traumatic Hydrocephalus Conditions
3.2 Global Acute External Ventricular Drain Sales Value by Type
3.2.1 Global Acute External Ventricular Drain Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Acute External Ventricular Drain Sales Value, by Type (2019-2030)
3.2.3 Global Acute External Ventricular Drain Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pediatric
4.1.2 Adult
4.2 Global Acute External Ventricular Drain Sales Value by Application
4.2.1 Global Acute External Ventricular Drain Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Acute External Ventricular Drain Sales Value, by Application (2019-2030)
4.2.3 Global Acute External Ventricular Drain Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Acute External Ventricular Drain Sales Value by Region
5.1.1 Global Acute External Ventricular Drain Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Acute External Ventricular Drain Sales Value by Region (2019-2024)
5.1.3 Global Acute External Ventricular Drain Sales Value by Region (2025-2030)
5.1.4 Global Acute External Ventricular Drain Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Acute External Ventricular Drain Sales Value, 2019-2030
5.2.2 North America Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Acute External Ventricular Drain Sales Value, 2019-2030
5.3.2 Europe Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Acute External Ventricular Drain Sales Value, 2019-2030
5.4.2 Asia Pacific Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Acute External Ventricular Drain Sales Value, 2019-2030
5.5.2 South America Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Acute External Ventricular Drain Sales Value, 2019-2030
5.6.2 Middle East & Africa Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Acute External Ventricular Drain Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Acute External Ventricular Drain Sales Value
6.3 United States
6.3.1 United States Acute External Ventricular Drain Sales Value, 2019-2030
6.3.2 United States Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Acute External Ventricular Drain Sales Value, 2019-2030
6.4.2 Europe Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Acute External Ventricular Drain Sales Value, 2019-2030
6.5.2 China Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.5.3 China Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Acute External Ventricular Drain Sales Value, 2019-2030
6.6.2 Japan Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Acute External Ventricular Drain Sales Value, 2019-2030
6.7.2 South Korea Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Acute External Ventricular Drain Sales Value, 2019-2030
6.8.2 Southeast Asia Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Acute External Ventricular Drain Sales Value, 2019-2030
6.9.2 India Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
6.9.3 India Acute External Ventricular Drain Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Profile
7.1.2 Medtronic Main Business
7.1.3 Medtronic Acute External Ventricular Drain Products, Services and Solutions
7.1.4 Medtronic Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.1.5 Medtronic Recent Developments
7.2 Integra LifeSciences Corporation
7.2.1 Integra LifeSciences Corporation Profile
7.2.2 Integra LifeSciences Corporation Main Business
7.2.3 Integra LifeSciences Corporation Acute External Ventricular Drain Products, Services and Solutions
7.2.4 Integra LifeSciences Corporation Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.2.5 Integra LifeSciences Corporation Recent Developments
7.3 Natus Medical Incorporated
7.3.1 Natus Medical Incorporated Profile
7.3.2 Natus Medical Incorporated Main Business
7.3.3 Natus Medical Incorporated Acute External Ventricular Drain Products, Services and Solutions
7.3.4 Natus Medical Incorporated Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.3.5 Fuji Systems Recent Developments
7.4 Fuji Systems
7.4.1 Fuji Systems Profile
7.4.2 Fuji Systems Main Business
7.4.3 Fuji Systems Acute External Ventricular Drain Products, Services and Solutions
7.4.4 Fuji Systems Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.4.5 Fuji Systems Recent Developments
7.5 Spiegelberg GmbH
7.5.1 Spiegelberg GmbH Profile
7.5.2 Spiegelberg GmbH Main Business
7.5.3 Spiegelberg GmbH Acute External Ventricular Drain Products, Services and Solutions
7.5.4 Spiegelberg GmbH Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.5.5 Spiegelberg GmbH Recent Developments
7.6 SOPHYSA
7.6.1 SOPHYSA Profile
7.6.2 SOPHYSA Main Business
7.6.3 SOPHYSA Acute External Ventricular Drain Products, Services and Solutions
7.6.4 SOPHYSA Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.6.5 SOPHYSA Recent Developments
7.7 Neuromedex
7.7.1 Neuromedex Profile
7.7.2 Neuromedex Main Business
7.7.3 Neuromedex Acute External Ventricular Drain Products, Services and Solutions
7.7.4 Neuromedex Acute External Ventricular Drain Revenue (US$ Million) & (2019-2024)
7.7.5 Neuromedex Recent Developments
8 Industry Chain Analysis
8.1 Acute External Ventricular Drain Industrial Chain
8.2 Acute External Ventricular Drain Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Acute External Ventricular Drain Sales Model
8.5.2 Sales Channel
8.5.3 Acute External Ventricular Drain Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Acute External Ventricular Drain Market Trends
Table 2. Acute External Ventricular Drain Market Drivers & Opportunity
Table 3. Acute External Ventricular Drain Market Challenges
Table 4. Acute External Ventricular Drain Market Restraints
Table 5. Global Acute External Ventricular Drain Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Acute External Ventricular Drain Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Acute External Ventricular Drain Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Acute External Ventricular Drain Product Type
Table 9. Key Companies Time to Begin Mass Production of Acute External Ventricular Drain
Table 10. Global Acute External Ventricular Drain Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute External Ventricular Drain as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Acute External Ventricular Drain Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Acute External Ventricular Drain Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Acute External Ventricular Drain Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Acute External Ventricular Drain Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Acute External Ventricular Drain Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Acute External Ventricular Drain Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Acute External Ventricular Drain Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Acute External Ventricular Drain Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Acute External Ventricular Drain Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Acute External Ventricular Drain Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Acute External Ventricular Drain Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Acute External Ventricular Drain Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Acute External Ventricular Drain Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Acute External Ventricular Drain Sales Value by Region (2019-2024) & (%)
Table 27. Global Acute External Ventricular Drain Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Acute External Ventricular Drain Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Acute External Ventricular Drain Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Acute External Ventricular Drain Sales Value, (2025-2030) & (US$ Million)
Table 31. Medtronic Basic Information List
Table 32. Medtronic Description and Business Overview
Table 33. Medtronic Acute External Ventricular Drain Products, Services and Solutions
Table 34. Revenue (US$ Million) in Acute External Ventricular Drain Business of Medtronic (2019-2024)
Table 35. Medtronic Recent Developments
Table 36. Integra LifeSciences Corporation Basic Information List
Table 37. Integra LifeSciences Corporation Description and Business Overview
Table 38. Integra LifeSciences Corporation Acute External Ventricular Drain Products, Services and Solutions
Table 39. Revenue (US$ Million) in Acute External Ventricular Drain Business of Integra LifeSciences Corporation (2019-2024)
Table 40. Integra LifeSciences Corporation Recent Developments
Table 41. Natus Medical Incorporated Basic Information List
Table 42. Natus Medical Incorporated Description and Business Overview
Table 43. Natus Medical Incorporated Acute External Ventricular Drain Products, Services and Solutions
Table 44. Revenue (US$ Million) in Acute External Ventricular Drain Business of Natus Medical Incorporated (2019-2024)
Table 45. Natus Medical Incorporated Recent Developments
Table 46. Fuji Systems Basic Information List
Table 47. Fuji Systems Description and Business Overview
Table 48. Fuji Systems Acute External Ventricular Drain Products, Services and Solutions
Table 49. Revenue (US$ Million) in Acute External Ventricular Drain Business of Fuji Systems (2019-2024)
Table 50. Fuji Systems Recent Developments
Table 51. Spiegelberg GmbH Basic Information List
Table 52. Spiegelberg GmbH Description and Business Overview
Table 53. Spiegelberg GmbH Acute External Ventricular Drain Products, Services and Solutions
Table 54. Revenue (US$ Million) in Acute External Ventricular Drain Business of Spiegelberg GmbH (2019-2024)
Table 55. Spiegelberg GmbH Recent Developments
Table 56. SOPHYSA Basic Information List
Table 57. SOPHYSA Description and Business Overview
Table 58. SOPHYSA Acute External Ventricular Drain Products, Services and Solutions
Table 59. Revenue (US$ Million) in Acute External Ventricular Drain Business of SOPHYSA (2019-2024)
Table 60. SOPHYSA Recent Developments
Table 61. Neuromedex Basic Information List
Table 62. Neuromedex Description and Business Overview
Table 63. Neuromedex Acute External Ventricular Drain Products, Services and Solutions
Table 64. Revenue (US$ Million) in Acute External Ventricular Drain Business of Neuromedex (2019-2024)
Table 65. Neuromedex Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Acute External Ventricular Drain Downstream Customers
Table 69. Acute External Ventricular Drain Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Acute External Ventricular Drain Product Picture
Figure 2. Global Acute External Ventricular Drain Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 4. Acute External Ventricular Drain Report Years Considered
Figure 5. Global Acute External Ventricular Drain Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute External Ventricular Drain Revenue in 2023
Figure 7. Acute External Ventricular Drain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Traumatic Brain Injury Picture
Figure 9. Subarachnoid Hemorrhage Picture
Figure 10. Intracerebral Hemorrhage Picture
Figure 11. Other Non-traumatic Hydrocephalus Conditions Picture
Figure 12. Global Acute External Ventricular Drain Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Acute External Ventricular Drain Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Pediatric
Figure 15. Product Picture of Adult
Figure 16. Global Acute External Ventricular Drain Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Acute External Ventricular Drain Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Acute External Ventricular Drain Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Acute External Ventricular Drain Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Acute External Ventricular Drain Sales Value (%), (2019-2030)
Figure 29. United States Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 35. China Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 37. China Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 47. India Acute External Ventricular Drain Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Acute External Ventricular Drain Sales Value by Type (%), 2023 VS 2030
Figure 49. India Acute External Ventricular Drain Sales Value by Application (%), 2023 VS 2030
Figure 50. Acute External Ventricular Drain Industrial Chain
Figure 51. Acute External Ventricular Drain Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
